EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic value of serum albumin level in patients with diffuse large B cell lymphoma

Liyan Chen, Lili Pan, Tingbo Liu

Acta Biochimica Polonica · 05.12.2023

DOI: 10.18388/abp.2020_6171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biochimica Polonica, online erschienen am 05.12.2023. Verfasst von Liyan Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Zhuhai Maternity and Child Health Hospital, Zhuhai, China; Fujian Medical University Union Hospital, Fujian, China. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the prognostic value of serum albumin (SA) levels before chemotherapy in patients with diffuse large B-cell lymphoma (DLBCL) after receiving chemotherapy.

Methods

This is a retrospective study, and 127 patients with DLBCL including 71 males (55.9%) and 56 females (44.1%) were included. Patients’ gender, age, Ann Arbor staging, eastern cooperative oncology group (ECOG) score, treatment options, international prognostic index, response rate, overall survival (OS), and progression-free survival (PFS) were obtained for statistical analysis.

Results

Univariate analysis showed that SA≤34 g/L, Ann Arbor III-IV, B symptoms, ECOG≥2, and bone marrow involvement suggest a poor prognosis in patients with DLBCL. Patients with persistent SA>34 g/L had significantly longer OS than patients with persistent SA≤34 g/L (P=0.020). Multivariate analysis showed that SA≤34 g/L (HR=0.48, 95% CI=0.26-0.90, P=0.022) and R-CHOP-like treatment regimen (HR=0.43, 95% CI=0.24-0.76, P=0.004) are independent factors that could affect the prognosis of patients with DLBCL.

Conclusion

SA can be used as an indicator of prognosis in patients with DLBCL before the first chemotherapy. DLBCL patients with SA≤34 g/L are associated with short OS and poor prognosis, which may potentially provide guidance for the clinician to pay more attention to this population before the first chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseMaleFemaleHumansPrognosisRetrospective StudiesDisease-Free SurvivalAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideDoxorubicinSerum Albumin

Substanzen

CyclophosphamideDoxorubicinSerum Albumin

Autor:innen und Institutionen

  • Department of Breast Surgery, Zhuhai Maternity and Child Health Hospital, Zhuhai, China; Fujian Medical University Union Hospital, Fujian, China.
  • Pediatric Hematology Department, Fujian Medical University Union Hospital, Fujian, China.
  • Hematology Department, Fujian Medical University Union Hospital, Fujian, China.

Zitieren

APA

Chen, L., Pan, L., & Liu, T. (2023). Prognostic value of serum albumin level in patients with diffuse large B cell lymphoma. Acta Biochimica Polonica. https://doi.org/10.18388/abp.2020_6171

Vancouver

Chen L, Pan L, Liu T. Prognostic value of serum albumin level in patients with diffuse large B cell lymphoma. Acta Biochimica Polonica. 2023. doi:10.18388/abp.2020_6171

BibTeX
@article{Chen2023,
  author = {Chen, Liyan and Pan, Lili and Liu, Tingbo},
  title = {Prognostic value of serum albumin level in patients with diffuse large B cell lymphoma},
  journal = {Acta Biochimica Polonica},
  year = {2023},
  doi = {10.18388/abp.2020_6171}
}
Kostenlos starten →